In Vivo Treg Suppression Assays
- 7 January 2011
- book chapter
- Published by Springer Nature
- Vol. 707, 119-156
- https://doi.org/10.1007/978-1-61737-979-6_9
Abstract
To fully examine the functionality of a regulatory T cell (Treg) population, one needs to assess their ability to suppress in a variety of in vivo models. We describe five in vivo models that examine the suppressive capacity of Tregs upon different target cell types. The advantages and disadvantages of each model including resources, time, and technical expertise required to execute each model are also described.Keywords
This publication has 33 references indexed in Scilit:
- Regulatory T cells and inhibitory cytokines in autoimmunityCurrent Opinion in Immunology, 2009
- Th1, Th17, and Th9 Effector Cells Induce Experimental Autoimmune Encephalomyelitis with Different Pathological PhenotypesThe Journal of Immunology, 2009
- The Key Role of Segmented Filamentous Bacteria in the Coordinated Maturation of Gut Helper T Cell ResponsesImmunity, 2009
- Induction of Intestinal Th17 Cells by Segmented Filamentous BacteriaCell, 2009
- The Foxp3+ regulatory T cell: a jack of all trades, master of regulationNature Immunology, 2008
- The inhibitory cytokine IL-35 contributes to regulatory T-cell functionNature, 2007
- Induction of Postsurgical Tumor Immunity and T-Cell Memory by a Poorly Immunogenic TumorCancer Research, 2007
- IL-23 is essential for T cell–mediated colitis and promotes inflammation via IL-17 and IL-6Journal of Clinical Investigation, 2006
- IL-23 drives a pathogenic T cell population that induces autoimmune inflammationThe Journal of Experimental Medicine, 2005
- CD4+CD25+ TR Cells Suppress Innate Immune Pathology Through Cytokine-dependent MechanismsThe Journal of Experimental Medicine, 2003